Jonathan Nebeker
Jonathan Nebeker
Professor of Medicine, University of Utah
Verified email at
Cited by
Cited by
Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting
JR Nebeker, P Barach, MH Samore
Annals of internal medicine 140 (10), 795-801, 2004
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project
JR Nebeker, R Virmani, CL Bennett, JM Hoffman, MH Samore, J Alvarez, ...
Journal of the American College of Cardiology 47 (1), 175-181, 2006
High rates of adverse drug events in a highly computerized hospital
JR Nebeker, JM Hoffman, CR Weir, CL Bennett, JF Hurdle
Archives of internal medicine 165 (10), 1111-1116, 2005
Risk factors for adverse drug events: a 10-year analysis
RS Evans, JF Lloyd, GJ Stoddard, JR Nebeker, MH Samore
Annals of Pharmacotherapy 39 (7-8), 1161-1168, 2005
Direct text entry in electronic progress notes
CR Weir, JF Hurdle, MA Felgar, JM Hoffman, B Roth, JR Nebeker
Methods of information in medicine 42 (01), 61-67, 2003
The research on adverse drug events and reports (RADAR) project
CL Bennett, JR Nebeker, EA Lyons, MH Samore, MD Feldman, JM McKoy, ...
Jama 293 (17), 2131-2140, 2005
A cognitive task analysis of information management strategies in a computerized provider order entry environment
CR Weir, JJR Nebeker, BL Hicken, R Campo, F Drews, B LeBar
Journal of the American Medical Informatics Association 14 (1), 65-75, 2007
Medication reconciliation: barriers and facilitators from the perspectives of resident physicians and pharmacists
KS Boockvar, SL Santos, A Kushniruk, C Johnson, JR Nebeker
Journal of Hospital Medicine 6 (6), 329-337, 2011
Prescribing discrepancies likely to cause adverse drug events after patient transfer
KS Boockvar, S Liu, N Goldstein, J Nebeker, A Siu, T Fried
BMJ Quality & Safety 18 (1), 32-36, 2009
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?
EA Richey, EA Lyons, JR Nebeker, V Shankaran, JM McKoy, TH Luu, ...
Journal of clinical oncology 27 (26), 4398, 2009
pSCANNER: Patient-centered scalable national network for effectiveness research
L Ohno-Machado, Z Agha, DS Bell, L Dahm, ME Day, JN Doctor, ...
Journal of the American Medical Informatics Association 21 (4), 621-626, 2014
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports …
LA Ladewski, SM Belknap, JR Nebeker, O Sartor, EA Lyons, TC Kuzel, ...
Journal of clinical oncology 21 (20), 3859-3866, 2003
Histologic features of human orbicularis oculi treated with botulinum A toxin
CP Harris, K Alderson, J Nebeker, JB Holds, RL Anderson
Archives of ophthalmology 109 (3), 393-395, 1991
Effect of admission medication reconciliation on adverse drug events from admission medication changes
KS Boockvar, S Blum, A Kugler, E Livote, KA Mergenhagen, JR Nebeker, ...
Archives of internal medicine 171 (9), 860-861, 2011
Pharmacist-versus physician-initiated admission medication reconciliation: impact on adverse drug events
KA Mergenhagen, SS Blum, A Kugler, EE Livote, JR Nebeker, MC Ott, ...
The American journal of geriatric pharmacotherapy 10 (4), 242-250, 2012
Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review
S Phansalkar, JM Hoffman, JR Nebeker, JF Hurdle
American journal of health-system pharmacy 64 (8), 842-849, 2007
Synonym, topic model and predicate-based query expansion for retrieving clinical documents
QT Zeng, D Redd, T Rindflesch, J Nebeker
AMIA Annual Symposium Proceedings 2012, 1050, 2012
Using ICD-9-CM codes in hospital claims data to detect adverse events in patient safety surveillance
P Hougland, J Nebeker, S Pickard, M Van Tuinen, C Masheter, S Elder, ...
Advances in patient safety: new directions and alternative approaches (Vol …, 2008
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and …
CL Bennett, JR Nebeker, PR Yarnold, CC Tigue, DA Dorr, JM McKoy, ...
Archives of internal medicine 167 (10), 1041-1049, 2007
Evaluation of the impact of a CPOE System on Nurse-physician communication
H Pirnejad, Z Niazkhani, H van der Sijs, M Berg, R Bal
Methods of information in medicine 48 (04), 350-360, 2009
The system can't perform the operation now. Try again later.
Articles 1–20